Studies have shown that active fund managers routinely underperform the S&P500 index*​

CONMED Corporation (NYSE: CNMD)

CNMD Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
16.20%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-39.50%

CNMD Stock Analysis

CNMD PE Ratio: 18.7

CNMD PEG Ratio: 1.7

CNMD Forward EPS Growth (12 month): 10.80%

CNMD PS Ratio: 0.7

CNMD PSG Ratio: 0.1

CNMD Forward Revenue Growth (12 month): 5.50%

CNMD Articles

No data was found